根据名称进行药物检索

Timoptic-XE Ocumeter与心动过缓/ AV阻滞

Timoptic-XE Ocumeter与心动过缓/ AV阻滞安全配伍检测的结果。

检测结果:

Timoptic-XE Ocumeter <> 心动过缓/ AV阻滞

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

利用眼貝塔-肾上腺素受体阻断剂(又名的β受体阻滞剂)被认为是可由制造商为被禁忌的患者窦緩慢性心律失常或心块大于第一个学位(除非一个正常运作的起搏器是存在的话)。局部应用的β受体阻滞剂是有系统地吸收，有可能产生临床上的重大系统性影响，甚至在低或无法检测的血浆水平。在心脏组织中，β封锁导致减少在变力以及变时性活动，这可以进一步降低心脏功能在这样的病人。

来源

"Product Information. Betagan Liquifilm (levobunolol)." Allergan Inc, Irvine, CA.
"Product Information. OptiPranolol (metipranolol)." Bausch and Lomb, Tampa, FL.
Edeki TI, He H, Wood AJ "Pharmacogenetic explanation for excessive B-blockade following timolol eye drops." JAMA 274 (1995): 1611-3
Shiuey Y, Eisenberg MJ "Cardiovascular effects of commonly used ophthalmic medications." Clin Cardiol 19 (1996): 5-8
Crean PA, Williams DO "Effect of intravenous and oral acebutolol in patients with bundle branch block." Int J Cardiol 10 (1986): 119-26
Uusitalo RJ, Palkama A "Efficacy and safety of timolol pilocarpine combination drops in glaucoma patients." Acta Ophthalmol (Copenh) 72 (1994): 496-504
"Product Information. Betaxon (levobetaxolol ophthalmic)" Alza, Palo Alto, CA.
Treseder AS, Thomas TP "Sinus arrest due to timolol eye drops." Br J Clin Pract 40 (1986): 256-8
Benjamin KW "Toxicity of ocular medications." Int Ophthalmol Clin 19 (1979): 199-255
"Product Information. Timoptic (timolol ophthalmic)." Merck & Co, Inc, West Point, PA.
Mashford ML, Coventry D, Hecker R, et al. "Adverse Drug Reactions Advisory Committee: ADRAC report for 1980." Med J Aust 1 (1982): 416-9
"Product Information. Betoptic (betaxolol ophthalmic)." Alcon Laboratories Inc, Fort Worth, TX.
"Product Information. Ocupress (carteolol ophthalmic)" Ciba Vision Ophthalmics, Duluth, GA.